To register for the showcase, click here. Please contact your A.G.P. representative to schedule a one-on-one investor meeting with the PDS Biotech leadership team. Following the event, an archived ...

A Philadelphia entrepreneur developing eye repair tech stood out among international contenders as it gears up to raise a ...

Shift Bioscience, a Cambridge-based biotech company using an AI powered virtual cell to fight age-driven diseases, has ...

Fortress Biotech, Inc. (“Fortress”) is an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue ...

During the presentation, Dr. Beetham will discuss the Company's progress in advancing its gene-editing technology platform, recent regulatory developments supporting agricultural innovation, and Cibus ...

Medicxi’s stripped-back approach has undoubtedly influenced Z Factor’s “virtual biotech company” set-up. This means it has no internal operations, and instead using a network of out ...

Omada Health filed for an IPO on Friday, the latest digital health company to announce its intent to test the public market.

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection. In March 23andMe said ...

“The use of a ‘virtual human twin’ for medical research ... Skourides underlined that the Cypriot nano-biotechnology company EPOS – IASIS, for example, recently participated in a cutting ...

Bio-Gene Technology Limited announced its participation in the NWR Virtual Healthcare Conference 2025, where CEO Tim Grogan will present the company’s advancements in bio-insecticides.

2:00 p.m. – 2:30 p.m. ET: Fireside Chat 5:00 p.m. – 6:00 p.m. ET: Panel Presentation: Development Stage Companies – Where Do Royalty and Tech Platform Plays Fit? To register for the ...